At a glance
- Originator Fujisawa
- Class Antihypertensives
- Mechanism of Action Endothelin-converting enzyme 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 20 Jun 2001 No-Development-Reported for Hypertension in Japan (Unknown route)
- 23 Jun 1998 Commercial data has been reviewed by Fujisawa
- 03 Jul 1996 New profile